Kaleido Historical Balance Sheet

Trend analysis of Kaleido Biosciences balance sheet accounts such as Cash and Equivalents of 58.6 M provides information on Kaleido Biosciences' total assets, liabilities, and equity, which is the actual value of Kaleido Biosciences to its prevalent stockholders. By breaking down trends over time using Kaleido Biosciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Kaleido Biosciences prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kaleido Biosciences is a good buy for the upcoming year.
Please see Stocks Correlation.

Search Historical Statements 

 
Refresh
Share

About Kaleido Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Kaleido Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Kaleido Biosciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kaleido Biosciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kaleido currently owns. An asset can also be divided into two categories, current and non-current.

Kaleido Biosciences Balance Sheet Chart

Kaleido Biosciences Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Kaleido Biosciences uses and utilizes its capital. It also shows what exactly a company owns and owes.
Kaleido Biosciences Shareholders Equity is quite stable at the moment as compared to the past year. The company's current value of Shareholders Equity is estimated at 22.11 Million. Liabilities Non Current is expected to rise to about 23.3 M this year, although the value of Assets Non Current will most likely fall to about 10.1 M.

Total Assets

Total assets refers to the total amount of Kaleido Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kaleido Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; [Investments]; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Kaleido Biosciences include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Kaleido Biosciences. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Kaleido Biosciences balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Kaleido Biosciences books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; [DeferredRev]; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Kaleido Biosciences balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Kaleido Biosciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please see Stocks Correlation.Kaleido Biosciences Shareholders Equity is quite stable at the moment as compared to the past year. The company's current value of Shareholders Equity is estimated at 22.11 Million. Liabilities Non Current is expected to rise to about 23.3 M this year, although the value of Assets Non Current will most likely fall to about 10.1 M.
 2018 2019 2020 2021 (projected)
Current Assets76.24 M73.28 M48.72 M58.47 M
Total Assets85.33 M82.31 M59.34 M68.54 M

Kaleido Biosciences balance sheet Correlations

Kaleido Biosciences Account Relationship Matchups

Kaleido Biosciences Investors Sentiment

The influence of Kaleido Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Kaleido. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - KLDO

Kaleido Biosciences Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Kaleido Biosciences. What is your trading attitude regarding investing in Kaleido Biosciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Kaleido Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Tools for Kaleido Stock

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go